Shandong Dongyue Organosilicon Materials Co Ltd
Shandong Dongyue Organosilicon Materials Co Ltd produces and sells organosilicon materials, primarily used in the chemical industry for applications such as silicone resins, silicone oils, and silicone rubber.
Business. Shandong Dongyue Organosilicon Materials Co Ltd (300821.SZ) is a specialty chemicals company headquartered in China. The firm operates within the Basic Materials sector, focusing on the production and sale of organosilicon materials. It is primarily listed on the Shenzhen Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Shandong Dongyue Organosilicon Materials Co Ltd (300821.SZ) is a specialty chemicals company headquartered in China. The firm operates within the Basic Materials sector, focusing on the production and sale of organosilicon materials. It is primarily listed on the Shenzhen Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not available.
The company's capital structure is characterized by a low debt-to-equity ratio of 0.09, indicating a conservative leverage position. However, the negative net income of -19.31 million CNY and an operating loss of -26.80 million CNY suggest financial stress. The liquidity position is mixed, with a current ratio of 2.44, but the company has negative net cash after subtracting total debt, signaling potential liquidity risk.
Profitability metrics are weak, with a return on equity of -0.39% and a return on assets of -0.33%. The gross profit of 166.88 million CNY is significantly lower than the operating and net losses, indicating high operating costs or inefficiencies. These figures fall below the typical performance of the Specialty Chemicals industry, which usually maintains positive returns and higher gross margins.
Geographically, the company's revenue is concentrated in China, with no disclosed international operations. Segment-wise, the company operates as a single business unit, which increases exposure to regional and industry-specific risks. The lack of diversification could amplify the impact of domestic economic or regulatory changes.
The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent period. The operating cash flow of 215.19 million CNY and free cash flow of 314.38 million CNY suggest some cash generation, but the negative net income and operating income indicate that this is not translating into profitability. The capital expenditure of -21.41 million CNY shows some investment in growth, but the scale is limited.
Risk factors include the company's negative net income and operating income, which raise concerns about its ability to sustain operations and meet obligations. The low dilution risk is supported by the absence of significant share issuance or dilution mechanisms in the recent financial data. However, the negative net cash position and the high price-to-book ratio of 3.88 suggest that the company may be overvalued relative to its tangible assets.
Recent events include the latest financial filing, which discloses the company's negative net income and operating loss. No recent earnings call transcripts or significant regulatory filings have been reported, limiting insight into management's strategic direction or operational improvements.
- The company has a low debt-to-equity ratio but is currently reporting negative net income and operating income.
- The return on equity and return on assets are negative, indicating poor profitability.
- The company's revenue is concentrated in a single geographic region and operates as a single business segment.
- The company generates positive operating and free cash flows but is not translating this into profitability.
- The company's valuation appears to be high relative to its tangible book value.
- The risk of dilution is low, but the company's liquidity position is medium due to negative net cash after debt.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Shandong Dongyue Organosilicon Materials Co Ltd Market data — financials · 2026-05-26